China's Sinovac defends Covid-19 vaccine after disappointing Brazil data | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Friday
June 02, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
FRIDAY, JUNE 02, 2023
China's Sinovac defends Covid-19 vaccine after disappointing Brazil data

Coronavirus chronicle

Reuters
13 January, 2021, 05:40 pm
Last modified: 13 January, 2021, 05:43 pm

Related News

  • China's Sinovac Covid-19 booster weaker against Omicron - Hong Kong study
  • Brazil health regulator suspends use of 12 million Sinovac vaccine shots
  • North Korea turns down Sinovac Covid-19 vaccine doses
  • Antibodies from Sinovac's Covid-19 shot fade after about 6 months, booster helps - study
  • Sinovac’s Covid-19 vaccine gains China approval for emergency use in children, adolescents

China's Sinovac defends Covid-19 vaccine after disappointing Brazil data

The vaccine was just 50.4% effective at preventing symptomatic infections in the Brazilian trial, including data on "very mild" cases, researchers said on Tuesday

Reuters
13 January, 2021, 05:40 pm
Last modified: 13 January, 2021, 05:43 pm
A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter
A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter

China's Sinovac Biotech defended the safety and efficacy of its experimental Covid-19 vaccine on Wednesday, after researchers in Brazil released late-stage clinical data showing efficacy that was much lower than initially announced.

The vaccine was just 50.4% effective at preventing symptomatic infections in the Brazilian trial, including data on "very mild" cases, researchers said on Tuesday.

Last week, they said the vaccine, called CoronaVac, showed 78% efficacy against "mild-to-severe" cases.

The news prompted Malaysia and Singapore, which have purchase agreements with Sinovac, to say on Wednesday that they would seek more data from the Chinese firm on efficacy rates before they approved and bought supplies.

"These Phase III clinical trial results are sufficient to prove that CoronaVac vaccine's safety and effectiveness are good around the world," Sinovac Biotech Chairman Yin Weidong told a news conference.

Different countries used vaccines from the same batch in their trials, but the countries don't have identical testing protocols, he said.

Piecemeal disclosures from Sinovac's trials as well as those from studies of other Chinese vaccines have raised concerns that they are not subject to the same public scrutiny as US and European alternatives.

The data from Brazil was released just as Indonesia rolled its vaccination campaign, with President Joko Widodo being the first to be inoculated with Sinovac's CoronaVac.

Malaysia said on Wednesday it would only go ahead with procurement if the vaccine satisfied the safety and efficacy standards of local regulators.

On Tuesday, Malaysia's Pharmaniaga Bhd signed a deal with Sinovac to purchase 14 million doses of CoronaVac and later to manufacture it domestically.

Singapore, the only high-income nation with which Sinovac has struck a deal, said it would go through official data when Sinovac releases it, rather than depending on efficacy reported so far, and then decide whether to approve it.

Thailand, which has ordered 2 million doses of CoronaVac said it was still on track to receive and administer the vaccine starting next month, but added it would ask for information directly from Sinovac.

Top News

Sinovac Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Budget made on unrealistic assumptions, targets are illusory: CPD
    Budget made on unrealistic assumptions, targets are illusory: CPD
  • NDB to finance water supply and gas pipeline construction projects in Bangladesh
    NDB to finance water supply and gas pipeline construction projects in Bangladesh
  • Photo: Md Jahidul Islam
    Dhaka North blacklists contractor company for felling trees on road dividers

MOST VIEWED

  • Covid is no longer global health emergency: WHO
    Covid is no longer global health emergency: WHO
  • Federal police officers stand guard near the house of former Brazilian President Jair Bolsonaro, during a search operation at his home, in Brasilia, Brazil, 3 May, 2023. REUTERS/Adriano Machado
    Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • World Health Organization logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. REUTERS/Dado Ruvic/Illustration//File Photo
    Covid here to stay but moving out of emergency phase: WHO
  • India's active case count now stands at 3.90 per cent. ( HT file Photo)
    India reports 12,591 new Covid cases today, 20% more than yesterday
  • People queue up outside a quick test centre to take their coronavirus disease (Covid-19) antigen rapid tests, in Singapore September 21, 2021. Photo :Reuters
    Singapore witnesses new Covid wave: ‘Cases are mostly mild’
  • India's active case count now stands at 3.90 per cent. ( HT file Photo)
    India logs 5,676 new Covid cases, active infections cross 37,000-mark

Related News

  • China's Sinovac Covid-19 booster weaker against Omicron - Hong Kong study
  • Brazil health regulator suspends use of 12 million Sinovac vaccine shots
  • North Korea turns down Sinovac Covid-19 vaccine doses
  • Antibodies from Sinovac's Covid-19 shot fade after about 6 months, booster helps - study
  • Sinovac’s Covid-19 vaccine gains China approval for emergency use in children, adolescents

Features

Photo: Md Adnan Khairullah

Above six thousand metres

20h | Features
Photo: Collected

Al Faya, one grain at a time

21h | Explorer
Illustration: TBS

Runaway non-food inflation remains the bigger culprit, but unchecked

1d | Panorama
There are more than 20 similar shops on Nilkhet footpath that sell tea, biscuits, crockeries, kitchenwares, bedsheets, mats, manicure sets, etc and all carry the logos and marks of different medicines and pharmaceutical companies in Bangladesh. 
Photo: Noor A Alam

Uncovering a treasure trove of pharma co gifts in Nilkhet's footpaths

2d | Panorama

More Videos from TBS

Budget reflects IMF conditions

Budget reflects IMF conditions

3h | TBS Economy
Awarness and vaccination can prevent cervical cancer

Awarness and vaccination can prevent cervical cancer

3h | TBS Health
Prices up, prices down

Prices up, prices down

18h | TBS Economy
6% inflation rate highly ambitious: Selim Raihan

6% inflation rate highly ambitious: Selim Raihan

18h | TBS Economy

Most Read

1
bKash denied permission to pay $4.10 lakh for Argentina football partnership
Banking

bKash denied permission to pay $4.10 lakh for Argentina football partnership

2
File Photo: Mohammad Minhaj Uddin/TBS
Bangladesh

Low-cost housing planned for 4 lakh Bangabandhu Shilpa Nagar workers

3
Boeing offers Biman its latest 787-10 Dreamliner
Bangladesh

Boeing offers Biman its latest 787-10 Dreamliner

4
Country's first floating solar power plant connected to national grid
Energy

Country's first floating solar power plant connected to national grid

5
Govt to double gain tax on land, flat registration
Budget

Govt to double gain tax on land, flat registration

6
Photo: TBS
Environment

Green space in Dhaka North declines 66% in 3 decades: Study

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]